FGF receptor genes and breast cancer susceptibility: Results from the Breast Cancer Association Consortium

British Journal of Cancer

Volumn 110, Issue 4, 2014, Pages 1088-1100

  Agarwal, D ^a,b   Pineda, S ^a   Michailidou, K ^c   Herranz, J ^a,d   Pita, G ^a   Moreno, L T ^a   Alonso, M R ^a   Dennis, J ^c   Wang, Q ^c   Bolla, M K ^c   Meyer, K B ^c   Menendez Rodriguez P ^e   Hardisson, D ^f   Mendiola, M ^g   Gonzalez Neira A ^a   Lindblom, A ^h   Margolin, S ^h   Swerdlow, A ⁱ   Ashworth, A ⁱ   Orr, N ⁱ   Jones, M ⁱ   Matsuo, K ^j   Ito, H ^k   Iwata, H ^k   Kondo, N ^k   Hartman, M ^l   Hui, M ⁿ   Lim, W Y ⁿ   Iau, P T C ⁿ   Sawyer, E ^o   Tomlinson, I ^p,q   Kerin, M ^r   Miller, N ^r   Kang, D ^s,t   Choi, J Y ^t   Park, S ^s,t   Noh, D Y ^s   Hopper, J L ^u   Schmidt, D F ^u   Makalic, E ^u   Southey, M C ^v   Teo, S H ^w,x   Yip, C H ^x   Sivanandan, K ^w   Tay, W T ^y   Brauch, H ^z,aa   Bruning T ^ab   Hamann, U ^ac   Dunning, A M ^c   Shah, M ^c   Andrulis, I L ^ad,ae   Knight, J A ^ad,af   Glendon, G ^ad   Tchatchou, S ^c   Schmidt, M K ^ag   Broeks, A ^ag   Rosenberg, E H ^ag   van't Veer, L J ^ag   Fasching, P A ^ah,ai   Renner, S P ^ah   Ekici, A B ^ah   Beckmann, M W ^ah   Shen, C Y ^aj,ak   Hsiung, C N ^aj   Yu, J C ^ak   Hou, M F ^am   Blot, W ^an   Cai, Q ^an   Wu, A H ^ao   Tseng, C C ^ao   Van Den Berg, D ^ao   Stram, D O ^ao   Cox, A ^ap   Brock, I W ^ap   Reed, M W R ^ap   Muir, K ^aq,ar   Lophatananon, A ^ar   Stewart Brown, S ^ar   Siriwanarangsan, P ^as   Zheng, W ^at   Deming Halverson, S ^at   Shrubsole, M J ^at   Long, J ^at   Shu, X O ^at   Lu, W ^au   Gao, Y T ^av   Zhang, B ^at   Radice, P ^aw   Peterlongo, P ^ax   Manoukian, S ^aw   Mariette, F ^ax,ay   Sangrajrang, S ^az   McKay, J ^ba   Couch, F J ^bb   Toland, A E ^bc   Yannoukakos, D ^bd   Fletcher, O ⁱ   Johnson, N ⁱ   Dos Santos Silva, I ^be   Peto, J ^be   Marme, F ^bf   Burwinkel, B ^ac,bf   Guenel P ^bg,bh   Truong, T ^bg,bh   Sanchez, M ^bg,bh   Mulot, C ^bg,bi   Bojesen, S E ^bj   Nordestgaard, B G ^bj   Flyer, H ^bj   Brenner, H ^ac   Dieffenbach, A K ^ac   Arndt, V ^ac   Stegmaier, C ^bk   Mannermaa, A ^bl,bm   Kataja, V ^bl,bm   Kosma, V M ^bl,bm   Hartikainen, J M ^bl,bm   Lambrechts, D ^bn   Yesilyurt, B T ^bn   Floris, G ^bo   Leunen, K ^bo   Chang Claude, J ^ac   Rudolph, A ^ac   Seibold, P ^ac   Flesch Janys, D ^bp   Wang, X ^bb   Olson, J E ^bb   Vachon, C ^bb   Purrington, K ^bb   Giles, G G ^u,bq   Severi, G ^u,bq   Baglietto, L ^u,bq   Haiman, C A ^ao   Henderson, B E ^ao   Schumacher, F ^ao   Le Marchand, L ^br   Simard, J ^bs   Dumont, M ^bs   Goldberg, M S ^bt,bu   Labreche F ^bv   Winqvist, R ^bw   Pylkas K ^bw   Jukkola Vuorinen, A ^bx   Grip, M ^bx   Devilee, P ^by   E M Tollenaar, R A ^by   Seynaeve, C ^bz   Garcia Closas M ^i,ca   Chanock, S J ^ca   Lissowska, J ^cb   Figueroa, J D ^ca   Czene, K ^h   Eriksson, M ^h   Humphreys, K ^h   Darabi, H ^h   Hooning, M J ^bz   Kriege, M ^bz   Collee J M ^bz   Tilanus Linthorst, M ^bz   Li, J ^cc   Jakubowska, A ^cd   Lubinski, J ^cd   Jaworska Bieniek, K ^cd   Durda, K ^cd   Nevanlinna, H ^ce   Muranen, T A ^ce   Aittomaki K ^ce   Blomqvist, C ^ce   Bogdanova, N ^cf   Dork T ^cf   Hall, P ^h   Chenevix Trench, G ^m   Easton, D F ^c,ac   P Pharoah, P D ^c,ac   Arias Perez, J I ^e   Zamora, P ^cg   Benitez J ^a   Milne, R L ^a,u,al   more..

^a Structural Biology and Biocomputing Programme   (Spain)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d IMDEA FOOD INSTITUTE   (Spain)

^e HOSPITAL MONTE NARANCO   (Spain)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^j KYUSHU UNIVERSITY   (Japan)

^k AICHI CANCER CENTER HOSPITAL   (Japan)

^l QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^m NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁿ NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^s Seoul National University College of Medicine   (South Korea)

^t Seoul National University   (South Korea)

^u UNIVERSITY OF MELBOURNE   (Australia)

^v UNIVERSITY OF MELBOURNE   (Australia)

^w CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^x UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^y NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^z DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^aa UNIVERSITY OF TÜBINGEN   (Germany)

^ab RUHR UNIVERSITY BOCHUM   (Germany)

^ac GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ad MOUNT SINAI HOSPITAL   (Canada)

^ae UNIVERSITY OF TORONTO   (Canada)

^af UNIVERSITY OF TORONTO   (Canada)

^ag ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^ah UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^ai UNIVERSITY OF CALIFORNIA   (United States)

^aj INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^ak CHINA MEDICAL UNIVERSITY   (Taiwan)

^al TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^am KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^an VANDERBILT UNIVERSITY   (United States)

^ao UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ap UNIVERSITY OF SHEFFIELD   (United Kingdom)

^aq UNIVERSITY OF MANCHESTER   (United Kingdom)

^ar UNIVERSITY OF WARWICK   (United Kingdom)

^as MINISTRY OF PUBLIC HEALTH   (Thailand)

^at VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^au Shanghai Center for Disease Control and Prevention   (China)

^av SHANGHAI CANCER INSTITUTE   (China)

^aw NATIONAL CANCER INSTITUTE   (Italy)

^ax FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^ay Cogentech Cancer Genetic Test Laboratory ^*  (Italy)

^az NATIONAL CANCER INSTITUTE   (Thailand)

^ba INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^bb MAYO CLINIC   (United States)

^bc OHIO STATE UNIVERSITY   (United States)

^bd INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^be LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^bf UNIVERSITY OF HEIDELBERG   (Germany)

^bg NATIONAL INSTITUTES OF HEALTH   (United States)

^bh CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^bi Centre de ressources biologiques (CRB) Epigenetec   (France)

^bj GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^bk SAARLAND CANCER REGISTRY   (Germany)

^bl UNIVERSITY OF EASTERN FINLAND   (Finland)

^bm KUOPIO UNIVERSITY HOSPITAL   (Finland)

^bn DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^bo UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bp UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^bq CANCER EPIDEMIOLOGY CENTRE   (Australia)

^br UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^bs University Laval   (Canada)

^bt MCGILL UNIVERSITY   (Canada)

^bu ROYAL VICTORIA HOSPITAL   (Canada)

^bv UNIVERSITÉ DE MONTRÉAL   (Canada)

^bw UNIVERSITY OF OULU   (Finland)

^bx OULU UNIVERSITY HOSPITAL   (Finland)

^by LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^bz ERASMUS MEDICAL CENTER   (Netherlands)

^ca NATIONAL CANCER INSTITUTE   (United States)

^cb INSTITUTE OF ONCOLOGY   (Poland)

^cc GENOME INSTITUTE OF SINGAPORE   (Singapore)

^cd POMERANIAN MEDICAL UNIVERSITY   (Poland)

^ce HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^cf HANNOVER MEDICAL SCHOOL   (Germany)

^cg HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 5;

EID: 84894304619     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.769     Document Type: Article

References (40)

1. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Stratton MR, Rahman N, Jacobs K, Prentice R, Anderson GL, Rajkovic A, Curb JD, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Diver WR, Bojesen S, Nordestgaard BG, Flyger H, Dork T, Schurmann P, Hillemanns P, Karstens JH, Bogdanova NV, Antonenkova NN, Zalutsky IV, Bermisheva M, Fedorova S, Khusnutdinova E, Kang D, Yoo KY, Noh DY, Ahn SH, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Garcia-Closas M, Lissowska J, Brinton L, Peplonska B, Nevanlinna H, Heikkinen T, Aittomaki K, Blomqvist C, Hopper JL, Southey MC, Smith L, Spurdle AB, Schmidt MK, Broeks A, van Hien RR, Cornelissen S, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Schmutzler RK, Burwinkel B, Bartram CR, Meindl A, Brauch H, Justenhoven C, Hamann U, Chang-Claude J, Hein R, Wang-Gohrke S (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590.
2. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130.
3. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R, Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D, Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras A, Caron O, Hardouin A, Berthet P, Hogervorst FB, Rookus MA, Jager A, Van Den Ouweland A, Hoogerbrugge N, Van Der Luijt RB, Meijers-Heijboer H, Gomez Garcia EB, Devilee P, Vreeswijk MP, Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski T, Gorski B, Cybulski C, Spurdle AB, Holland H, Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 42: 885-892.
4. Aulchenko YS, Ripke S, Isaacs A, Van Duijn CM (2007) GenABEL: An R library for genome-wide association analysis. Bioinformatics 23: 1294-1296.
5. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
6. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Ghoussaini M, Ahmed S, Baynes C, Bolla MK, Wang Q, Dennis J, McGuffog L, Barrowdale D, Lee A, Healey S, Lush M, Tessier DC, Vincent D, Bacot F, Vergote I, Lambrechts S, Despierre E, Risch HA, Gonzalez-Neira A, Rossing MA, Pita G, Doherty JA, Alvarez N, Larson MC, Fridley BL, Schoof N, Chang-Claude J, Cicek MS, Peto J, Kalli KR, Broeks A, Armasu SM, Schmidt MK, Braaf LM, Winterhoff B, Nevanlinna H, Konecny GE, Lambrechts D, Rogmann L, Guenel P, Teoman A, Milne RL, Garcia JJ, Cox A, Shridhar V, Burwinkel B, Marme F, Hein R, Sawyer EJ, Haiman CA, Wang-Gohrke S, Andrulis IL (2013) Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45: 371-384, 384. e1-e2.
7. Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, Lee JY, Chen K, Shen H, Shen CY, Sung H, Matsuo K, Haiman CA, Khoo US, Ren Z, Iwasaki M, Gu K, Xiang YB, Choi JY, Park SK, Zhang L, Hu Z, Wu PE, Noh DY, Tajima K, Henderson BE, Chan KY, Su F, Kasuga Y, Wang W, Cheng JR, Yoo KY, Zheng H, Liu Y, Shieh YL, Kim SW, Lee JW, Iwata H, Le Marchand L, Chan SY, Xie X, Tsugane S, Lee MH, Wang S, Li G, Levy S, Huang B, Shi J, Delahanty R, Zheng Y, Li C, Gao YT, Shu XO, Zheng W (2011) Genome-wide association study identifies breast cancer risk variant at 10q21.2: Results from the Asia Breast Cancer Consortium. Hum Mol Genet 20: 4991-4999.
8. Chen GJ, Forough R (2006) Fibroblast growth factors, fibroblast growth factor receptors, diseases, and drugs. Recent Pat Cardiovasc Drug Discov 1: 211-224.
9. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
10. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16: 139-149.
11. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, Zelenika D, Gut I, Heath S, Palles C, Coupland B, Broderick P, Schoemaker M, Jones M, Williamson J, Chilcott-Burns S, Tomczyk K, Simpson G, Jacobs KB, Chanock SJ, Hunter DJ, Tomlinson IP, Swerdlow A, Ashworth A, Ross G, dos Santos Silva I, Lathrop M, Houlston RS, Peto J (2011) Novel breast cancer susceptibility locus at 9q31.2: Results of a genome-wide association study. J Natl Cancer Inst 103: 425-435.
12. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, Brauch H, Chang-Claude J, Carpenter J, Godwin AK, Nevanlinna H, Giles GG, Cox A, Hopper JL, Bolla MK, Wang Q, Dennis J, Dicks E, Howat WJ, Schoof N, Bojesen SE, Lambrechts D, Broeks A, Andrulis IL, Guenel P, Burwinkel B, Sawyer EJ, Hollestelle A, Fletcher O, Winqvist R, Brenner H, Mannermaa A, Hamann U, Meindl A, Lindblom A, Zheng W, Devillee P, Goldberg MS, Lubinski J, Kristensen V, Swerdlow A, Anton-Culver H, Dork T, Muir K, Matsuo K, Wu AH, Radice P, Teo SH, Shu XO, Blot W, Kang D, Hartman M, Sangrajrang S, Shen CY, Southey MC, Park DJ, Hammet F, Stone J, Veer LJ, Rutgers EJ, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Peto J, Schrauder MG, Ekici AB, Beckmann MW, Dos Santos Silva I, Johnson N, Warren H, Tomlinson I, Kerin MJ, Miller N, Marme F, Schneeweiss A, Sohn C, Truong T, Laurent-Puig P, Kerbrat P, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Perez JI, Menendez P, Muller H, Arndt V, Stegmaier C, Lichtner P, Lochmann M, Justenhoven C, Ko YD, Muranen TA, Aittomaki K. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 45: 392-398, 398. e1-e2.
13. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dork T, Schurmann P, Hillemanns P, Bogdanova N, Bremer M, Karstens JH, Fagerholm R, Aaltonen K, Aittomaki K, von Smitten K, Blomqvist C, Mannermaa A, Uusitupa M, Eskelinen M, Tengstrom M, Kosma VM, Kataja V, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Devilee P, van Asperen CJ, Jacobi CE, Tollenaar RA, Huijts PE, Klijn JG, Chang-Claude J, Kropp S, Slanger T, Flesch-Janys D, Mutschelknauss E, Salazar R, Wang-Gohrke S, Couch F, Goode EL, Olson JE, Vachon C, Fredericksen ZS, Giles GG, Baglietto L, Severi G, Hopper JL, English DR, Southey MC, Haiman CA, Henderson BE, Kolonel LN, Le Marchand L, Stram DO, Hunter DJ, Hankinson SE, Cox DG, Tamimi R, Kraft P, Sherman ME, Chanock SJ, Lissowska J, Brinton LA, Peplonska B, Hooning MJ, Meijers-Heijboer H, Collee JM (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4: E1000054.
14. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, Johnson N, Orr N, dos Santos Silva I, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Hall P, Czene K, Irwanto A, Liu J, Nevanlinna H, Aittomaki K, Blomqvist C, Meindl A, Schmutzler RK, Muller-Myhsok B, Lichtner P, Chang-Claude J, Hein R, Nickels S, Flesch-Janys D, Tsimiklis H, Makalic E, Schmidt D, Bui M, Hopper JL, Apicella C, Park DJ, Southey M, Hunter DJ, Chanock SJ, Broeks A, Verhoef S, Hogervorst FB, Fasching PA, Lux MP, Beckmann MW, Ekici AB, Sawyer E, Tomlinson I, Kerin M, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guenel P, Truong T, Cordina-Duverger E, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Alonso MR, Gonzalez-Neira A, Benitez J, Anton-Culver H, Ziogas A, Bernstein L, Dur CC, Brenner H, Muller H, Arndt V, Stegmaier C, Justenhoven C, Brauch H, Bruning T, Wang-Gohrke S, Eilber U, Dork T, Schurmann P, Bremer M, Hillemanns P, Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Manoukian S, Bonanni B, Fortuzzi S, Peterlongo P, Couch FJ, Wang X, Stevens K, Lee A, Giles GG, Baglietto L, Severi G, McLean C, Alnaes GG, Kristensen V, Borrensen-Dale AL, John EM, Miron A, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Glendon G, Mulligan AM, Devilee P, van Asperen CJ, Tollenaar RA, Seynaeve C, Figueroa JD, Garcia-Closas M, Brinton L, Lissowska J, HooningMJ, Hollestelle A, Oldenburg RA (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 44: 312-318.
15. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos AM, Driver WR, Dunnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA, Feigelson HS, Flesch-Janys D, Fostira F, Forsti A, Fountzilas G, Gerty SM, Giles GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson SE, Hartmann A, Hein R, Heinz J, Holbrook A, Hoover RN, Hu JJ, Hunter DJ, Ingles SA, Irwanto A, Ivanovich J, John EM, Johnson N, Jukkola-Vuorinen A, Kaaks R, Ko YD, Kolonel LN, Konstantopoulou I, Kosma VM, Kulkarni S, Lambrechts D, Lee AM, Marchand LL, Lesnick T, Liu J, Lindstrom S, Mannermaa A, Margolin S (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 43: 1210-1214.
16. Haldane JBS (1954) An exact test for randomness of mating. J Genet 52: 631-635.
17. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-Analysis. Stat Med 21: 1539-1558.
18. Huijts PE, Van Dongen M, de Goeij MC, van Moolenbroek AJ, Blanken F, Vreeswijk MP, de Kruijf EM, Mesker WE, van Zwet EW, Tollenaar RA, Smit VT, van Asperen CJ, Devilee P (2011) Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Breast Cancer Res 13: R72.
19. Hunter DJ, Kraft P, Jacobs KB, Cox DG, YeagerM, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, Wang J, Yu K, Chatterjee N, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Hayes RB, Tucker M, Gerhard DS, Fraumeni Jr. JF, Hoover RN, Thomas G, Chanock SJ (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874.
20. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95: 221-227.
21. Meijers-Heijboer H, Van Den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, Van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR (2002) Low-penetrance susceptibility to breast cancer due to CHEK2 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31: 55-59.
22. Meyer KB, Maia AT, O'Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BA (2008) Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6: E108.
23. Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't Veer LJ, Hogervorst FB, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Lux MP, Ekici AB, Beckmann MW, Peto J, Dos Santos Silva I, Fletcher O, Johnson N, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Zamora MP, Arias JI, Benitez J, Neuhausen S, Anton-Culver H, Ziogas A, Dur CC, Brenner H, Müller H, Arndt V, Stegmaier C, Meindl A, Schmutzler RK, Engel C, Ditsch N, Brauch H, Brüning T, Ko YD, The GENICA Network, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Matsuo K, Ito H, Iwata H, Yatabe Y, Dörk T, Helbig S, Bogdanova NV, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G, kConFab Investigators, Australian Ovarian Cancerr
24. Study Group, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Lambrechts D, Thienpont B, Christiaens MR, Smeets A, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Bernard L, Couch FJ, Olson JE, Wang X, Purrington K, Giles GG, Severi G, Baglietto L, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Teo SH, Yip CH, Phuah SY, Kristensen V, Grenaker Alnæs G, Børresen-Dale AL, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Devilee P, Tollenaar RA, Seynaeve CM, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson K, Hooning MJ, Martens JW, Van Den Ouweland AM, Van Deurzen CH, Hall P, Li J, Liu J, Humphreys K, Shu XO, LuW, Gao YT, Cai H, Cox A, Reed MW, Blot W (2013) Fine-scale mapping of the FGFR2 breast cancer risk locus: Putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 93(6): 1046-1060.
25. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomaki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M, Van Der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, Muller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF, Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC, Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X, Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Rudolph A, Nickels S, Flesch-Janys D, Johnson N (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 45: 353-361, 361. e1-e2.
26. Nyholt DR (2004) A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769.
27. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2005) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178.
28. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D, Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167.
29. Robertson A, Hill WG (1984) Deviations from Hardy-Weinberg proportions: Sampling variances and use in estimation of inbreeding coefficients. Genetics 107: 703-718.
30. Schwertfeger KL (2009) Fibroblast growth factors in development and cancer: Insights from the mammary and prostate glands. Curr Drug Targets 10: 632-644.
31. Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K, North B, McGuffog L, Evans DG, Eccles D, Easton DF, Stratton MR, Rahman N (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38: 1239-1241.
32. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomaki K, Amiano P, Apicella C, Baglietto L, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Brauch H, Brinton L, Bui QM, Buring JE, Buys SS, Campa D, Carpenter JE, Chasman DI, Chang-Claude J, Chen C, Clavel-Chapelon F, Cox A, Cross SS, Czene K, Deming SL, Diasio RB, Diver WR, Dunning AM, Durcan L, Ekici AB, Fasching PA, Feigelson HS, Fejerman L, Figueroa JD, Fletcher O, Flesch-Janys D, Gaudet MM, Gerty SM, Rodriguez-Gil JL, Giles GG, van Gils CH, Godwin AK, Graham N, Greco D, Hall P, Hankinson SE, Hartmann A, Hein R, Heinz J (2012) A meta-Analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 21: 5373-5384.
33. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A, Aben KK, Strobbe LJ, Albers-Akkers MT, Swinkels DW, Henderson BE, Kolonel LN, Le Marchand L, Millastre E, Andres R, Godino J, Garcia-Prats MD, Polo E, Tres A, Mouy M, Saemundsdottir J, Backman VM, Gudmundsson L, Kristjansson K, Bergthorsson JT, Kostic J, Frigge ML, Geller F, Gudbjartsson D, Sigurdsson H, Jonsdottir T, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Jonsson T, von Holst S, Werelius B, Margolin S, Lindblom A, Mayordomo JI, Haiman CA, Kiemeney LA, Johannsson OT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869.
34. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, Jakobsdottir M, Bergthorsson JT, Gudmundsson J, Aben KK, Strobbe LJ, Swinkels DW, van Engelenburg KC, Henderson BE, Kolonel LN, Le Marchand L, Millastre E, Andres R, Saez B, Lambea J, Godino J, Polo E, Tres A, Picelli S, Rantala J, Margolin S, Jonsson T, Sigurdsson H, Jonsdottir T, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Sveinsdottir SG, Alexiusdottir K, Saemundsdottir J, Sigurdsson A, Kostic J, Gudmundsson L, Kristjansson K, Masson G, Fackenthal JD, Adebamowo C, Ogundiran T, Olopade OI, Haiman CA, Lindblom A, Mayordomo JI, Kiemeney LA, Gulcher JR, Rafnar T, Thorsteinsdottir U, Johannsson OT, Kong A, Stefansson K (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40: 703-706.
35. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-Telangiectasia. N Engl J Med 316: 1289-1294.
36. The Breast Cancer Association Consortium (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98: 1382-1396.
37. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, Hankinson SE, Hutchinson A, Wang Z, Yu K, Chatterjee N, Garcia-Closas M, Gonzalez-Bosquet J, Prokunina-Olsson L, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Diver R, Prentice R, Jackson R, Kooperberg C, Chlebowski R, Lissowska J, Peplonska B, Brinton LA, Sigurdson A, Doody M, Bhatti P, Alexander BH, Buring J, Lee IM, Vatten LJ, Hveem K, Kumle M, Hayes RB, Tucker M, Gerhard DS, Fraumeni Jr. JF, Hoover RN, Chanock SJ, Hunter DJ (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41: 579-584.
38. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, Hughes D, Warren-Perry M, Tapper W, Eccles D, Evans DG, Hooning M, Schutte M, Van Den Ouweland A, Houlston R, Ross G, Langford C, Pharoah PD, Stratton MR, Dunning AM, Rahman N, Easton DF (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
39. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J, Doody DR, MacArthur S, Tyrer J, Pharoah PD, Luben R, Bernstein L, Kolonel LN, Henderson BE, Le Marchand L, Ursin G, Press MF, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Kang D, Yoo KY, Noh DY, Ahn SH, Ponder BA, Haiman CA, Malone KE, Dunning AM, Ostrander EA, Easton DF (2009) FGFR2 variants and breast cancer risk: Fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 18: 1692-1703.
40. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, Wen W, Levy S, Deming SL, Haines JL, Gu K, Fair AM, Cai Q, Lu W, Shu XO (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41: 324-328.